Rare diseases
Investigational molecules
Locations
Back to France663 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis
FranceStudy on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease
FranceStudy on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment
FranceStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
FranceStudy on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years
FranceStudy on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events
FranceStudy on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease
FranceStudy on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment
FranceStudy on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida
FranceStudy on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer
FranceStudy on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection
FranceStudy on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.
Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.
Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.
Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.
Cutting-edge treatments being developed to address both rare and common neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
